Arrowhead Pharmaceuticals Initiates Phase 2 Study of ARC-AAT
Go back to Arrowhead Pharmaceuticals Initiates Phase 2 Study of ARC-AAT| ARROWHEAD RESEARCH (NASDAQ: ARWR) | Delayed: 85.40 +2.66 (3.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $82.74 | 52 Week High | $8.22 | |||
| Open | $82.87 | 52 Week Low | $3.07 | |||
| Day High | $85.47 | P/E | N/A | |||
| Day Low | $82.09 | EPS | $-1.30 | |||
| Volume | 1,122,240 | |||||
